Free Trial

Clover Health Investments (CLOV) Short Interest Ratio & Short Volume

Clover Health Investments logo
$3.40 -0.05 (-1.45%)
As of 04/30/2025 04:00 PM Eastern

Clover Health Investments Short Interest Data

Clover Health Investments (CLOV) has a short interest of 12.37 million shares, representing 3.18% of the float (the number of shares available for trading by the public). This marks a 2.74% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 6.82 million shares to cover all short positions.

Current Short Interest
12,370,000 shares
Previous Short Interest
12,040,000 shares
Change Vs. Previous Month
+2.74%
Dollar Volume Sold Short
$46.02 million
Short Interest Ratio
2.1 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
510,907,000 shares
Short Percent of Float
3.18%
Today's Trading Volume
3,560,970 shares
Average Trading Volume
6,823,492 shares
Today's Volume Vs. Average
52%
Short Selling Clover Health Investments?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Clover Health Investments and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLOV Short Interest Over Time

CLOV Days to Cover Over Time

CLOV Percentage of Float Shorted Over Time

Clover Health Investments Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202512,370,000 shares $46.02 million +2.7%3.2%2.1 $3.72
3/31/202512,040,000 shares $43.22 million -8.4%3.1%1.9 $3.59
3/15/202513,140,000 shares $48.09 million +10.4%3.4%2.2 $3.66
2/28/202511,900,000 shares $47.24 million -22.4%3.1%2 $3.97
2/15/202515,330,000 shares $68.37 million +1.7%3.9%2.8 $4.46
1/31/202515,080,000 shares $66.20 million -8.2%N/A2.4 $4.39
1/15/202516,420,000 shares $65.35 million +2.9%N/A2.6 $3.98
12/31/202415,960,000 shares $50.27 million +9.0%N/A2.6 $3.15
12/15/202414,640,000 shares $45.53 million -4.2%N/A2.1 $3.11
11/30/202415,280,000 shares $53.17 million -7.1%N/A2.1 $3.48
11/15/202416,440,000 shares $49.98 million -10.3%N/A2 $3.04
10/31/202418,330,000 shares $75.52 million +16.4%N/A1.9 $4.12
10/15/202415,750,000 shares $65.05 million -38.3%N/A1.7 $4.13
9/30/202425,510,000 shares $71.94 million -1.1%N/A3 $2.82
9/15/202425,800,000 shares $77.14 million +28.4%N/A3.5 $2.99
8/31/202420,090,000 shares $52.84 million -31.6%N/A2.6 $2.63
8/15/202429,360,000 shares $78.10 million -9.8%N/A4.3 $2.66
7/31/202432,550,000 shares $62.17 million -7.2%N/A5.3 $1.91
7/15/202435,080,000 shares $55.43 million -0.2%N/A6 $1.58
6/30/202435,160,000 shares $43.25 million -0.5%N/A5.8 $1.23
6/15/202435,320,000 shares $38.50 million -7.3%N/A5.2 $1.09
5/31/202438,080,000 shares $41.89 million -16.0%N/A4.5 $1.10
5/15/202445,330,000 shares $42.92 million -5.2%N/A4.8 $0.95
4/30/202447,810,000 shares $30.12 million -0.7%N/A5.1 $0.63
4/15/202448,160,000 shares $30.64 million +9.5%N/A5.2 $0.64
3/31/202443,980,000 shares $34.92 million -7.5%N/A4.7 $0.79
3/15/202447,540,000 shares $37.91 million +30.1%N/A4.9 $0.80
2/29/202436,540,000 shares $31.57 million +23.8%N/A4.3 $0.86
2/15/202429,520,000 shares $29.82 million +6.7%N/A3.9 $1.01
1/31/202427,680,000 shares $26.52 million -7.9%N/A3.7 $0.96
1/15/202430,040,000 shares $29.48 million +8.2%N/A4.2 $0.98
12/31/202327,760,000 shares $26.43 million +6.3%N/A4.1 $0.95
12/15/202326,110,000 shares $25.73 million +0.8%N/A4.4 $0.99
11/30/202325,900,000 shares $23.85 million +1.9%N/A5.4 $0.92
11/15/202325,430,000 shares $25.94 million +5.3%N/A6.2 $1.02
10/31/202324,150,000 shares $23.02 million -1.8%N/A5.7 $0.95
10/15/202324,600,000 shares $25.34 million -2.4%N/A6 $1.03
9/30/202325,200,000 shares $27.22 million +7.8%N/A5.1 $1.08
9/15/202323,370,000 shares $26.41 million +2.9%N/A3.8 $1.13
8/31/202322,720,000 shares $29.76 million +3.2%N/A2.7 $1.31
How to invest in Elon Musk’s Optimus before its launch (Ad)

Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.

8/15/202322,020,000 shares $31.27 million +1.5%N/A2.4 $1.42
7/31/202321,700,000 shares $27.13 million -4.6%N/A2.2 $1.25
7/15/202322,740,000 shares $22.70 million -0.8%N/A2.4 $1.00
6/30/202322,930,000 shares $20.57 million -39.4%N/A2.5 $0.90
6/15/202337,830,000 shares $37.63 million +8.8%N/A4.6 $0.99
5/31/202334,780,000 shares $29.46 million -7.4%N/A5.5 $0.85
5/15/202337,550,000 shares $36.51 million -5.7%N/A5.6 $0.97
4/30/202339,820,000 shares $29.41 million +10.7%N/A6.3 $0.74
4/15/202335,960,000 shares $29.75 million +11.3%N/A5.7 $0.83
3/31/202332,320,000 shares $27.31 million +12.3%N/A5.1 $0.85
3/15/202328,780,000 shares $26.61 million -6.6%N/A4.1 $0.92
2/28/202330,800,000 shares $40.66 million +4.7%N/A4.5 $1.32
2/15/202329,420,000 shares $36.19 million +1.3%N/A4.9 $1.23
1/31/202329,030,000 shares $38.61 million -4.4%N/A4.3 $1.33
1/15/202330,380,000 shares $37.67 million -0.3%N/A4.4 $1.24
12/30/202230,480,000 shares $28.33 million +2.6%N/A4.2 $0.93
12/15/202229,710,000 shares $30.90 million No ChangeN/A4 $1.04
11/30/202229,710,000 shares $38.92 million -0.1%N/A4.1 $1.31
11/15/202229,740,000 shares $43.72 million -3.9%N/A4 $1.47
10/31/202230,950,000 shares $48.90 million -3.2%N/A4 $1.58
10/15/202231,960,000 shares $48.26 million -9.9%N/A4.2 $1.51
9/30/202235,480,000 shares $60.32 million +0.7%N/A5 $1.70
9/15/202235,240,000 shares $82.11 million -1.9%N/A4.6 $2.33
8/31/202235,910,000 shares $93.73 million -0.2%N/A4.4 $2.61
8/15/202235,990,000 shares $116.97 million +0.3%N/A4.1 $3.25
7/31/202235,870,000 shares $100.44 million -1.1%N/A3.9 $2.80
7/15/202236,260,000 shares $90.29 million -6.4%N/A4 $2.49
6/30/202238,730,000 shares $82.88 million +27.8%N/A4.2 $2.14
6/15/202230,300,000 shares $67.57 million +3.8%N/A3.2 $2.23
5/31/202229,180,000 shares $77.91 million -5.1%N/A3.1 $2.67
5/15/202230,760,000 shares $80.28 million +4.6%N/A2.5 $2.61
4/30/202229,410,000 shares $79.11 million +0.9%N/A2.3 $2.69
4/15/202229,150,000 shares $90.66 million -3.2%N/A2.1 $3.11
3/31/202230,110,000 shares $106.89 million -8.3%N/A2 $3.55
3/15/202232,840,000 shares $94.58 million -9.6%N/A2.1 $2.88
2/28/202236,340,000 shares $98.84 million +7.0%N/A2.4 $2.72
2/15/202233,980,000 shares $86.99 million +21.6%N/A2.3 $2.56
1/31/202227,950,000 shares $72.11 million +6.5%N/A1.7 $2.58
1/15/202226,250,000 shares $81.64 million +6.3%N/A1.7 $3.11
12/31/202124,700,000 shares $91.88 million -4.8%N/A1.6 $3.72
12/15/202125,940,000 shares $107.13 million -1.3%N/A1.7 $4.13
11/30/202126,290,000 shares $130.40 million -17.7%N/A1.5 $4.96
11/15/202131,940,000 shares $241.47 million +9.5%N/A1.5 $7.56
10/29/202129,160,000 shares $218.70 million No ChangeN/A1.3 $7.50
10/15/202129,160,000 shares $230.66 million -8.4%N/A1.3 $7.91
9/30/202131,830,000 shares $235.22 million +2.6%N/A1.2 $7.39
9/15/202131,020,000 shares $253.43 million +1.3%N/A1 $8.17
8/31/202130,620,000 shares $262.72 million +1.2%N/A0.7 $8.58
8/13/202130,270,000 shares $248.82 million +19.8%N/A0.5 $8.22
7/30/202125,260,000 shares $203.85 million -11.7%18.9%0.5 $8.07
How to invest in Elon Musk’s Optimus before its launch (Ad)

Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.

7/15/202128,610,000 shares $236.32 million -20.3%21.4%0.5 $8.26
6/30/202135,890,000 shares $478.05 million -13.3%27.8%0.6 $13.32
6/15/202141,400,000 shares $570.08 million +0.3%36.7%0.8 $13.77
5/28/202141,270,000 shares $315.30 million +2.0%36.6%1 $7.64
5/14/202140,460,000 shares $293.74 million +7.7%36.1%1.8 $7.26
4/30/202137,580,000 shares $382.19 million -2.9%34.2%1.6 $10.17
4/15/202138,700,000 shares $287.15 million +0.5%35.2%1.6 $7.42
3/31/202138,500,000 shares $276.82 million +30.0%12.6%2.3 $7.19
3/15/202129,620,000 shares $263.91 million +20.3%9.7%1.7 $8.91
2/26/202124,620,000 shares $239.06 million +24.0%8.0%1.4 $9.71
2/12/202119,850,000 shares $238.40 million +55.6%6.5%1.4 $12.01
1/29/202112,760,000 shares $179.53 million +40.1%N/A1 $14.07
1/15/20219,110,000 shares $127.63 million No Change12.6%1 $14.01

CLOV Short Interest - Frequently Asked Questions

What is Clover Health Investments' current short interest?

Short interest is the volume of Clover Health Investments shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 12,370,000 shares of CLOV short. 3.18% of Clover Health Investments' shares are currently sold short. Learn More on Clover Health Investments' current short interest.

What is a good short interest ratio for Clover Health Investments?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLOV shares currently have a short interest ratio of 2.0. Learn More on Clover Health Investments's short interest ratio.

Which institutional investors are shorting Clover Health Investments?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clover Health Investments: IMC Chicago LLC, GTS Securities LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Clover Health Investments?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.18% of Clover Health Investments' floating shares are currently sold short.

Is Clover Health Investments' short interest increasing or decreasing?

Clover Health Investments saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 12,370,000 shares, an increase of 2.7% from the previous total of 12,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Clover Health Investments' short interest compare to its competitors?

3.18% of Clover Health Investments' shares are currently sold short. Here is how the short interest of companies in the industry of "insurance" compare to Clover Health Investments: Essent Group Ltd. (0.87%), Voya Financial, Inc. (1.59%), Jackson Financial Inc. (4.96%), Enact Holdings, Inc. (7.56%), The Baldwin Insurance Group, Inc. (7.41%), F&G Annuities & Life, Inc. (0.27%), Palomar Holdings, Inc. (2.48%), Goosehead Insurance, Inc (11.45%), Alignment Healthcare, Inc. (9.82%), Brighthouse Financial, Inc. (3.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Clover Health Investments stock?

Short selling CLOV is an investing strategy that aims to generate trading profit from Clover Health Investments as its price is falling. CLOV shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Clover Health Investments?

A short squeeze for Clover Health Investments occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLOV, which in turn drives the price of the stock up even further.

How often is Clover Health Investments' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLOV, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:CLOV) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners